OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glibenclamide mitigates cognitive impairment and hippocampal neuroinflammation in rats with type 2 diabetes and sporadic Alzheimer-like disease
Mohammad Hossein Esmaeili, Mohsen Enayati, Farhad Khabbaz Abkenar, et al.
Behavioural Brain Research (2019) Vol. 379, pp. 112359-112359
Closed Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Innate Immune Cell Death in Neuroinflammation and Alzheimer’s Disease
Y. Rajesh, Thirumala‐Devi Kanneganti
Cells (2022) Vol. 11, Iss. 12, pp. 1885-1885
Open Access | Times Cited: 148

The Role of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) in Diabetes-Related Neurodegenerative Diseases
Dihe Cheng, Shuo Yang, Xue Zhao, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 665-684
Open Access | Times Cited: 43

Brain insulin resistance mediated cognitive impairment and neurodegeneration: Type-3 diabetes or Alzheimer’s Disease
Abhilasha Ahlawat, Vaibhav Walia, Munish Garg
Acta Neurologica Belgica (2025)
Closed Access | Times Cited: 1

Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2022) Vol. 31, Iss. 1, pp. 1-7
Open Access | Times Cited: 37

Huang-Lian-Jie-Du decoction attenuates cognitive dysfunction of rats with type 2 diabetes by regulating autophagy and NLRP3 inflammasome activation
Ruimin Tian, Xianfeng Liu, Lijia Jing, et al.
Journal of Ethnopharmacology (2022) Vol. 292, pp. 115196-115196
Closed Access | Times Cited: 34

Association of sulfonylureas with the risk of dementia: A population‐based cohort study
Che‐Yuan Wu, Carina Iskander, Christa Wang, et al.
Journal of the American Geriatrics Society (2023) Vol. 71, Iss. 10, pp. 3059-3070
Open Access | Times Cited: 19

Repositioning of Anti-Diabetic Drugs against Dementia: Insight from Molecular Perspectives to Clinical Trials
Keren Esther Kristina Mantik, Sujin Kim, Bonsang Gu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11450-11450
Open Access | Times Cited: 17

Repurposing antidiabetic drugs for Alzheimer's disease: A review of preclinical and clinical evidence and overcoming challenges
Jacky Tran, Sneh Parekh, Julia Rockcole, et al.
Life Sciences (2024) Vol. 355, pp. 123001-123001
Closed Access | Times Cited: 8

Swimming exercise improves cognitive and behavioral disorders in male NMRI mice with sporadic Alzheimer-like disease
Hamideh Bashiri, Mohsen Enayati, Alireza Bashiri, et al.
Physiology & Behavior (2020) Vol. 223, pp. 113003-113003
Closed Access | Times Cited: 47

Prenatal maternal stress alters depression-related symptoms in a strain - and sex-dependent manner in rodent offspring
Mohsen Enayati, Belal Mosaferi, Judith R. Homberg, et al.
Life Sciences (2020) Vol. 251, pp. 117597-117597
Closed Access | Times Cited: 43

Dapagliflozin Improves High‐Fat Diet‐Induced Cognitive Impairment in Female Mice
Xiaolin Pang, Mingxia Fan, Zhuoni Xiao, et al.
Brain and Behavior (2025) Vol. 15, Iss. 2
Open Access

Silymarin sex-dependently improves cognitive functions and alters TNF-α, BDNF, and glutamate in the hippocampus of mice with mild traumatic brain injury
Ghaffar Shokouhi, Morteza Kosari‐Nasab, Ali‐Akbar Salari
Life Sciences (2020) Vol. 257, pp. 118049-118049
Closed Access | Times Cited: 30

Repurposing Drugs: A Promising Therapeutic Approach against Alzheimer’s Disease
Swagata Pattanaik, Aruna Ghose, Kakarla Pakeeraiah, et al.
Ageing Research Reviews (2025), pp. 102698-102698
Closed Access

Pharmacological Inhibition of Transient Receptor Potential Melastatin 2 (TRPM2) Channels Attenuates Diabetes-induced Cognitive Deficits in Rats: A Mechanistic Study
Pavan Thapak, Mahendra Bishnoi, Shyam Sunder Sharma
Current Neurovascular Research (2020) Vol. 17, Iss. 3, pp. 249-258
Closed Access | Times Cited: 24

Swimming exercise attenuates anxiety-like behavior by reducing brain oxidative stress in type 2 diabetic mice
Parinaz Matinfar, Maghsoud Peeri, Mohammad Ali Azarbayjani
Physiology & Behavior (2021) Vol. 237, pp. 113449-113449
Closed Access | Times Cited: 23

Perinatal fluoxetine dose-dependently affects prenatal stress-induced neurobehavioural abnormalities, HPA-axis functioning and underlying brain alterations in rat dams and their offspring
Mohammad Amani, Danielle J. Houwing, Judith R. Homberg, et al.
Reproductive Toxicology (2021) Vol. 104, pp. 27-43
Closed Access | Times Cited: 23

Adolescent swimming exercise following maternal valproic acid treatment improves cognition and reduces stress-related symptoms in offspring mice: Role of sex and brain cytokines
Ali Barzegari, Hassan Amouzad Mahdirejei, Masoumeh Hanani, et al.
Physiology & Behavior (2023) Vol. 269, pp. 114264-114264
Closed Access | Times Cited: 8

Environmental enrichment alters neurobehavioral development following maternal immune activation in mice offspring with epilepsy
Maryam Zeraati, Nazila Najdi, Belal Mosaferi, et al.
Behavioural Brain Research (2020) Vol. 399, pp. 112998-112998
Closed Access | Times Cited: 22

Swimming exercise decreases depression‐like behaviour and inflammatory cytokines in a mouse model of type 2 diabetes
Mohadeseh Gilak‐Dalasm, Maghsoud Peeri, Mohammad Ali Azarbayjani
Experimental Physiology (2021) Vol. 106, Iss. 9, pp. 1981-1991
Open Access | Times Cited: 19

Melatonin treatment improves cognitive deficits by altering inflammatory and neurotrophic factors in the hippocampus of obese mice
Soraya Mansouri, Ali‐Akbar Salari, Ali Abedi, et al.
Physiology & Behavior (2022) Vol. 254, pp. 113919-113919
Closed Access | Times Cited: 14

Clinical antidiabetic medication used in Alzheimer’s disease: From basic discovery to therapeutics development
Juan Huang, Nanqu Huang, Di Cui, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 7

Huang-Lian-Jie-Du decoction drug-containing serum inhibits IL-1β secretion from D-glucose and PA induced BV2 cells via autophagy/NLRP3 signaling
Ruimin Tian, Xianfeng Liu, Yang Xiao, et al.
Journal of Ethnopharmacology (2023) Vol. 323, pp. 117686-117686
Closed Access | Times Cited: 7

Role of 14-3-3 protein family in the pathobiology of EBV in immortalized B cells and Alzheimer’s disease
Prankur Awasthi, Dhruv Kumar, Saba Hasan
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 2

A gliclazide complex based on palladium towards Alzheimer's disease: promising protective activity against Aβ-induced toxicity in C. elegans
Amalia García-García, Sara Rojas, Lorenzo Rivas-García, et al.
Chemical Communications (2021) Vol. 58, Iss. 10, pp. 1514-1517
Open Access | Times Cited: 14

Mechanistic and Etiological Similarities in Diabetes Mellitus and Alzheimer’s Disease: Antidiabetic Drugs as Optimistic Therapeutics in Alzheimer’s Disease
Subham Das, A Ramachandran, Debojyoti Halder, et al.
CNS & Neurological Disorders - Drug Targets (2022) Vol. 22, Iss. 7, pp. 973-993
Closed Access | Times Cited: 9

Page 1 - Next Page

Scroll to top